HLA-DQB1: Difference between revisions
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS (v470) |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Major histocompatibility complex, class II, DQ beta 1''', also known as '''HLA-DQB1''', is a human [[gene]] and also denotes the genetic [[locus (genetics)|locus]] that contains this gene.<ref name = "Entrez_Gene_3119">{{cite web | title = Entrez Gene: HLA-DQB1 major histocompatibility complex, class II, DQ beta 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3119| accessdate = }}</ref> The [[protein]] encoded by this gene is one of two proteins that are required to form the [[HLA-DQ|DQ heterodimer]], a cell surface [[immune receptor|receptor]] essential to the function of the [[immune system]]. | ||
}} | |||
== Function == | |||
HLA-DQB1 belongs to the [[MHC class II|HLA class II]] beta chain [[Homology (biology)#Paralogy|paralogues]]. This class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in [[antigen-presenting cells]] (APC: B lymphocytes, dendritic cells, macrophages).<ref name = "Entrez_Gene_3119"/> | |||
==See also== | ==Gene structure and polymorphisms== | ||
The beta chain is approximately 26-28 kDa and it contains 5 [[exon]]s. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular [[protein domain]]s, exon 4 encodes the [[transmembrane protein|transmembrane]] domain, and exon 5 encodes the [[cytoplasm]]ic tail. Within the DQ molecule, both the alpha chain and the beta chain contain the [[polymorphism (biology)|polymorphism]]s specifying the peptide binding specificities, resulting in up to 4 different molecules. Typing for these polymorphisms is routinely done for [[hematopoietic stem cell transplantation|bone marrow transplantation]].<ref name = "Entrez_Gene_3119"/><ref name="pmid7547576">{{cite journal | vauthors = Lau M, Terasaki PI, Park MS | title = International Cell Exchange, 1994 | journal = Clinical Transplants | volume = | issue = | pages = 467–88 | year = 1994 | pmid = 7547576 | doi = }}</ref> | |||
==Disease association== | |||
===Diabetes=== | |||
Several [[allele]]s of HLA-DQB1 are associated with an increased risk of developing [[diabetes mellitus type 1|type 1 diabetes]].<ref name="pmid2187469">{{cite journal | vauthors = Todd JA | title = Genetic control of autoimmunity in type 1 diabetes | journal = Immunology Today | volume = 11 | issue = 4 | pages = 122–9 | date = April 1990 | pmid = 2187469 | doi = 10.1016/0167-5699(90)90049-F }}</ref><ref name="pmid9296067">{{cite journal | vauthors = Todd JA | title = Genetics of type 1 diabetes | journal = Pathologie-Biologie | volume = 45 | issue = 3 | pages = 219–27 | date = March 1997 | pmid = 9296067 | doi = }}</ref><ref name="pmid11237226">{{cite journal | vauthors = Redondo MJ, Fain PR, Eisenbarth GS | title = Genetics of type 1A diabetes | journal = Recent Progress in Hormone Research | volume = 56 | issue = | pages = 69–89 | year = 2001 | pmid = 11237226 | doi = 10.1210/rp.56.1.69 }}</ref> The locus also has the genetic name IDDM1 as it is the highest genetic risk for type 1 diabetes. Again the DQB1*0201 and DQB1*0302 alleles, particularly the phenotype DQB1*0201/*0302 has a high risk of late onset type 1 diabetes. The risk is partially shared with the HLA-DR locus (DR3 and DR4 serotypes). | |||
===Celiac disease=== | |||
Celiac1 is a genetic name for DQB1, the HLA DQB1*0201, *0202, and *0302 encode genes that mediate the [[autoimmune disease|autoimmune]] [[coeliac disease]]. Homozygotes of DQB1*0201 have a higher risk of developing the celiac disease, relative to any other genetic locus.<ref name="pmid17919990">{{cite journal | vauthors = Murray JA, Moore SB, Van Dyke CT, Lahr BD, Dierkhising RA, Zinsmeister AR, Melton LJ, Kroning CM, El-Yousseff M, Czaja AJ | title = HLA DQ gene dosage and risk and severity of celiac disease | journal = Clinical Gastroenterology and Hepatology | volume = 5 | issue = 12 | pages = 1406–12 | date = December 2007 | pmid = 17919990 | pmc = 2175211 | doi = 10.1016/j.cgh.2007.08.013 }}</ref> | |||
===Multiple sclerosis=== | |||
Certain HLA-DQB1 alleles are also linked to a modest increased risk of [[multiple sclerosis]].<ref name="pmid9300661">{{cite journal | vauthors = Dyment DA, Sadovnick AD, Ebers GC, Sadnovich AD | title = Genetics of multiple sclerosis | journal = Human Molecular Genetics | volume = 6 | issue = 10 | pages = 1693–8 | year = 1997 | pmid = 9300661 | doi = 10.1093/hmg/6.10.1693 }}</ref><ref name="pmid17329717">{{cite journal | vauthors = Schmidt H, Williamson D, Ashley-Koch A | title = HLA-DR15 haplotype and multiple sclerosis: a HuGE review | journal = American Journal of Epidemiology | volume = 165 | issue = 10 | pages = 1097–109 | date = May 2007 | pmid = 17329717 | doi = 10.1093/aje/kwk118 }}</ref> | |||
===Narcolepsy=== | |||
Other HLA-DQB1 alleles are associated with a predisposition to [[narcolepsy]],<ref name="pmid9582188">{{cite journal | vauthors = Kadotani H, Faraco J, Mignot E | title = Genetic studies in the sleep disorder narcolepsy | journal = Genome Research | volume = 8 | issue = 5 | pages = 427–34 | date = May 1998 | pmid = 9582188 | doi = 10.1101/gr.8.5.427 }}</ref> specifically HLA-DQB1*0602, which is carried by over 90% of patients with narcolepsy-cataplexy.<ref>{{cite web|title=Narcolepsy Research - FAQs|url=http://med.stanford.edu/psychiatry/narcolepsy/faq1.html|accessdate=3 January 2014}}</ref> | |||
==Alleles== | |||
{| class = "wikitable" | |||
|+ HLA-DQB1 alleles | |||
! Serotype || DQB1 allele | |||
|- | |||
| Rowspan = 3 | [[HLA-DQ2|DQ2]] ||[[HLA-DQ2#DQB1*0201|*0201]] | |||
|- | |||
|[[HLA-DQ2#DQB1*0202|*0202]] | |||
|- | |||
|[[HLA-DQ2#DQB1*0203|*0203]] | |||
|- | |||
| Rowspan = 2 | [[HLA-DQ4|DQ4]] ||[[HLA-DQ4#DQB1*0401|*0401]] | |||
|- | |||
|[[HLA-DQ4#DQB1*0402|*0402]] | |||
|- | |||
| Rowspan = 4 | [[HLA-DQ5|DQ5]] ||[[HLA-DQ5#DQB1*0501|*0501]] | |||
|- | |||
|[[HLA-DQ5#DQB1*0502|*0502]] | |||
|- | |||
|[[HLA-DQ5#DQB1*0503|*0503]] | |||
|- | |||
|[[HLA-DQ5#DQB1*0504|*0504]] | |||
|- | |||
| Rowspan = 6 | [[HLA-DQ6|DQ6]] ||[[HLA-DQ6#DQB1*0601|*0601]] | |||
|- | |||
|[[HLA-DQ6#DQB1*0602|*0602]] | |||
|- | |||
|[[HLA-DQ6#DQB1*0603|*0603]] | |||
|- | |||
|[[HLA-DQ6#DQB1*0604|*0604]] | |||
|- | |||
|[[HLA-DQ6#DQB1*0605|*0605]] | |||
|- | |||
|[[HLA-DQ6#DQB1*0609|*0609]] | |||
|- | |||
| Rowspan = 2 | [[HLA-DQ7|DQ7]] ||[[HLA-DQ7#DQB1*0301|*0301]] | |||
|- | |||
|[[HLA-DQ7#DQB1*0304|*0304]] | |||
|- | |||
| Rowspan = 2 | [[HLA-DQ8|DQ8]] ||[[HLA-DQ8#DQB1*0302|*0302]] | |||
|- | |||
|[[HLA-DQ8#DQB1*0305|*0305]] | |||
|- | |||
|[[HLA-DQ9|DQ9]]||[[HLA-DQ9#DQB1*0303|*0303]] | |||
|} | |||
== See also == | |||
* [[Major histocompatibility complex]] | * [[Major histocompatibility complex]] | ||
* [[Human leukocyte antigen]] | * [[Human leukocyte antigen]] | ||
* [[HLA-DQ]] | * [[HLA-DQ]] | ||
==References== | == References == | ||
{{reflist| | {{reflist|30em}} | ||
{{PDB_Gallery|geneid=3119}} | |||
{{Surface antigens}} | |||
[[Category:MHC Class II]] | |||
{{ | {{protein-stub}} | ||
Latest revision as of 00:18, 27 October 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Major histocompatibility complex, class II, DQ beta 1, also known as HLA-DQB1, is a human gene and also denotes the genetic locus that contains this gene.[1] The protein encoded by this gene is one of two proteins that are required to form the DQ heterodimer, a cell surface receptor essential to the function of the immune system.
Function
HLA-DQB1 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen-presenting cells (APC: B lymphocytes, dendritic cells, macrophages).[1]
Gene structure and polymorphisms
The beta chain is approximately 26-28 kDa and it contains 5 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular protein domains, exon 4 encodes the transmembrane domain, and exon 5 encodes the cytoplasmic tail. Within the DQ molecule, both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to 4 different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation.[1][2]
Disease association
Diabetes
Several alleles of HLA-DQB1 are associated with an increased risk of developing type 1 diabetes.[3][4][5] The locus also has the genetic name IDDM1 as it is the highest genetic risk for type 1 diabetes. Again the DQB1*0201 and DQB1*0302 alleles, particularly the phenotype DQB1*0201/*0302 has a high risk of late onset type 1 diabetes. The risk is partially shared with the HLA-DR locus (DR3 and DR4 serotypes).
Celiac disease
Celiac1 is a genetic name for DQB1, the HLA DQB1*0201, *0202, and *0302 encode genes that mediate the autoimmune coeliac disease. Homozygotes of DQB1*0201 have a higher risk of developing the celiac disease, relative to any other genetic locus.[6]
Multiple sclerosis
Certain HLA-DQB1 alleles are also linked to a modest increased risk of multiple sclerosis.[7][8]
Narcolepsy
Other HLA-DQB1 alleles are associated with a predisposition to narcolepsy,[9] specifically HLA-DQB1*0602, which is carried by over 90% of patients with narcolepsy-cataplexy.[10]
Alleles
Serotype | DQB1 allele |
---|---|
DQ2 | *0201 |
*0202 | |
*0203 | |
DQ4 | *0401 |
*0402 | |
DQ5 | *0501 |
*0502 | |
*0503 | |
*0504 | |
DQ6 | *0601 |
*0602 | |
*0603 | |
*0604 | |
*0605 | |
*0609 | |
DQ7 | *0301 |
*0304 | |
DQ8 | *0302 |
*0305 | |
DQ9 | *0303 |
See also
References
- ↑ 1.0 1.1 1.2 "Entrez Gene: HLA-DQB1 major histocompatibility complex, class II, DQ beta 1".
- ↑ Lau M, Terasaki PI, Park MS (1994). "International Cell Exchange, 1994". Clinical Transplants: 467–88. PMID 7547576.
- ↑ Todd JA (April 1990). "Genetic control of autoimmunity in type 1 diabetes". Immunology Today. 11 (4): 122–9. doi:10.1016/0167-5699(90)90049-F. PMID 2187469.
- ↑ Todd JA (March 1997). "Genetics of type 1 diabetes". Pathologie-Biologie. 45 (3): 219–27. PMID 9296067.
- ↑ Redondo MJ, Fain PR, Eisenbarth GS (2001). "Genetics of type 1A diabetes". Recent Progress in Hormone Research. 56: 69–89. doi:10.1210/rp.56.1.69. PMID 11237226.
- ↑ Murray JA, Moore SB, Van Dyke CT, Lahr BD, Dierkhising RA, Zinsmeister AR, Melton LJ, Kroning CM, El-Yousseff M, Czaja AJ (December 2007). "HLA DQ gene dosage and risk and severity of celiac disease". Clinical Gastroenterology and Hepatology. 5 (12): 1406–12. doi:10.1016/j.cgh.2007.08.013. PMC 2175211. PMID 17919990.
- ↑ Dyment DA, Sadovnick AD, Ebers GC, Sadnovich AD (1997). "Genetics of multiple sclerosis". Human Molecular Genetics. 6 (10): 1693–8. doi:10.1093/hmg/6.10.1693. PMID 9300661.
- ↑ Schmidt H, Williamson D, Ashley-Koch A (May 2007). "HLA-DR15 haplotype and multiple sclerosis: a HuGE review". American Journal of Epidemiology. 165 (10): 1097–109. doi:10.1093/aje/kwk118. PMID 17329717.
- ↑ Kadotani H, Faraco J, Mignot E (May 1998). "Genetic studies in the sleep disorder narcolepsy". Genome Research. 8 (5): 427–34. doi:10.1101/gr.8.5.427. PMID 9582188.
- ↑ "Narcolepsy Research - FAQs". Retrieved 3 January 2014.
This protein-related article is a stub. You can help Wikipedia by expanding it. |